Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer (Q36900726)
Jump to navigation
Jump to search
scientific article published on July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer |
scientific article published on July 2007 |
Statements
1 reference
Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer (English)
1 reference
Antoni Ribas
1 reference
Douglas C Hanson
1 reference
Dennis A Noe
1 reference
Robert Millham
1 reference
Deborah J Guyot
1 reference
Steven H Bernstein
1 reference
Paul C Canniff
1 reference
Amarnath Sharma
1 reference
Jesus Gomez-Navarro
1 reference
Identifiers
1 reference